Natus Medical Incorporated
Location
California
Founded
1987-02-13
Website
Risk Signals
313 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Electromedical and Electrotherapeutic Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Natus Medical Incorporated
Live alerts from global media, monitored by Business Radar
2021-08-06 (fool.com)
Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript |
NTUS earnings call for the period ending June 30, 2021.
Read more
2020-08-03 (massdevice.com)
Natus Medical slides on missed earnings projections
Natus Medical (NSDQ:NTUS) shares took a hit today on second-quarter results that came up short of the consensus earnings forecast. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted losses of-$ 8.9 million, or -26¢
Read more
2020-02-07 (massdevice.com)
Natus Medical stock takes a hit amid lower 2020 outlook
Natus Medical (NSDQ:NTUS) shares dipped today after the company lowered its 2020 sales guidance — even as it reported Q4 results met or slightly beat The Street. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted
Read more
2019-10-28 (massdevice.com)
Natus Medical gains on Q3 swing to black
Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street.
Read more
2016-09-26 (thestreet.com)
Natus Medical (BABY) Stock Drops on Downbeat Q3 Forecast
Natus Medical (BABY) cut its fiscal 2016 third-quarter revenue outlook due to a shortfall from halted production in its Seattle facility.
Read more
2016-09-26 (thestreet.com)
Natus Medical (BABY) Stock Drops on Downbeat Q3 Forecast
Natus Medical (BABY) cut its fiscal 2016 third-quarter revenue outlook due to a shortfall from halted production in its Seattle facility.
Read more
2016-06-25 (hearingreview.com)
GN Reports 12% Revenue Growth in 2016, 6% Organic Growth
GN Hearing reports that it gained market share in 2016 for the 6th consecutive year, underlining the company's continuing strong momentum.
Read more